Overview

Full Product Details

Author:   Eudenilson L. Albuquerque (Universidade Federal do Rio Grande do Norte (UFRN), Natal-RN, Brazil)
Publisher:   Elsevier - Health Sciences Division
Imprint:   Elsevier - Health Sciences Division
Weight:   0.450kg
ISBN:  

9780443155307

ISBN 10:   0443155305
Pages:   302
Publication Date:   29 February 2024
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

PART I: QUANTUM CHEMISTRY: A REVIEW 1. From classical to quantum physics (draft ready) 2. Main theoretical results 3. Computational approach PART II: IMMUNE-ONCOLOGICAL DRUGS 4. Cancer Immunotherapy 5. Immune-oncological drug Atezolizumab 6. Immune-oncological drug Nivolumab 7. Immune-oncological drug Pembrolizumab 8. Immune-oncological drug Ipilimumab 9. Optoelectronics properties PART III: TRANSVERSE ONCOLOGICAL DRUGS 10. Introduction 11. Oncological drugs complexed with the Human Serum Albumin (draft ready) 12. Anti- Breast cancer oncological drugs 13. Anti-Prostate cancer oncological drugs PART IV: LOOKING AHEAD 14. The future of the oncological drugs

Reviews

Author Information

Eudenilson L. Albuquerque is Professor of Physics and Biophysics, at the Department of Biophysics, UFRN, Brazil, where he served as Dean for Research and Graduate Studies (1987-1991). He has previously co-authored the books Polariton in Periodic and Quasiperiodic Structures (Elsevier, 2004) and Quantum Chemistry Simulation of Biological Molecules (Cambridge University Press, 2021).

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions